BioNTech SE (BNTX) vs Lufax Holding Ltd (LU)
A side-by-side comparison of BioNTech SE and Lufax Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: BNTX is classified in Healthcare; LU is classified in Financial Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
BNTX
BioNTech SE
$92.45HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
LU
Lufax Holding Ltd
$1.54Financial ServicesDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — BNTX vs LU
growth of $100 · dividends reinvested · last 6yBNTX +8.8%LU -92.5%BNTX compounded faster
Log scale — wide-divergence pair
BNTX LU
BNTX vs LU: by the numbers
- •BNTX is the larger company ($23.38B vs $646M market cap).
- •Both run net losses; LU's is the smaller (-11.38% vs -44.73% net margin).
- •BNTX grew revenue faster over the past five years (2.16% vs -12.94% CAGR).
Metrics side by side
Valuation
| Metric | BNTX | LU |
|---|---|---|
| P/S ratio | 7.01 | 0.17 |
| P/B ratio | 1.07 | 0.06 |
| FCF yield | 6.49% | N/A |
Profitability
| Metric | BNTX | LU |
|---|---|---|
| Gross margin | 73.26% | 74.93% |
| Operating margin | -22.63% | 0.57% |
| Net margin | -44.73% | -11.38% |
| ROE | -6.79% | -3.70% |
| ROIC | -3.14% | -0.21% |
Growth (annualized)
| Metric | BNTX | LU |
|---|---|---|
| Revenue CAGR (5Y) | 2.16% | -12.94% |
| EPS CAGR (5Y) | N/A | -43.16% |
| Total return CAGR (5Y) | -20.13% | -33.54% |
Frequently asked
- Which has grown faster, BNTX or LU?
- Over the past five years, BNTX grew revenue faster — BNTX at a 2.16% CAGR versus LU at -12.94%.
- How have BNTX and LU total returns compared?
- Over the past 5 years, BNTX delivered -20.13% and LU delivered -33.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioNTech SE P/E ratioLufax P/E ratioBioNTech SE dividend yieldLufax dividend yieldBioNTech SE ROELufax ROEBioNTech SE operating marginLufax operating marginBioNTech SE revenue growthLufax revenue growthBioNTech SE free cash flowLufax free cash flow
BioNTech SE & Lufax appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.